Dissection Necessary For Breast Cancer Patients With Positive Ultrasound Guided Axillary Node Biopsy
5/07/2012
Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, a new study shows...
Patient Recall Rates Reduced By 40 Percent With Digital Breast Tomosynthesis
5/07/2012
Adding digital breast tomosynthesis to 2D mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, a new study shows. The study, conducted at Yale University School of Medicine in New Haven, CT, of 7,578 screening mammograms, found that the recall rate was 6.6% for digital breast tomosynthesis plus 2D screening mammography...
Women Should Still Have Screening Mammograms Even If They Have 'No Family History'
5/07/2012
More than half the women aged 40-49 diagnosed with breast cancer on screening mammography report no family history, a new study shows. The study, conducted at Elizabeth Wende Breast Care, LLC in Rochester, NY of all breast cancers diagnosed between 2000 and 2010, found that 228 out of 373 cancers (61%) were found in women, aged 40-49 with no family history of breast cancer...
In Some Patients With Benign Papillomas, Surgical Excision Unnecessary
5/07/2012
Imaging surveillance is an acceptable alternative to surgical excision in patients with benign papilloma, diagnosed at breast core biopsy without cell abnormalities, a new study shows. The study, conducted at the Breast Health Center of California Pacific Medical Center in San Francisco, included 119 papillomas diagnosed at core biopsy without abnormal cells...
'Overmanagement' Of Benign Breast Disease Revealed By Study
5/07/2012
Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows. The study, conducted at Moffitt Cancer Center in Tampa, FL, followed 388 patients for six, 12 and 24 months. No cancer was found in these patients at six and 12 months, said Shannon Reed, MD, one of the authors of the study...
American and Spanish researchers have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests, as they reported at the 4th IMPAKT Breast Cancer Conference...
Understanding Of Breast Cancer's Multiple Varieties Improved By New Data
5/07/2012
New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers...
"Spaghetti Models" Of Cancer Progression Built To Fight Cancer
5/06/2012
Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer. According to Alexander R. A. Anderson, Ph.D...
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium. Everolimus is currently used as an immunosuppressant to prevent patients rejecting transplanted organs and in the treatment of renal cell cancer...
Presentation At Breast Cancer Conference Reveals Breast Cancer In Young Women Is A Distinct Disease
5/06/2012
Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers reported at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium, 3-5 May 2012...